Target Gene/Pathway Pathway / Gene


Search results


No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 Allograft rejection 💬
1件: TNFRSF5 💬 Bleselumab 💬 Bleselumab 1件: 222 💬
2 Allograft rejection 💬
1件: TNFRSF5 💬 Iscalimab 💬 Iscalimab 2件: 49, 53 💬
3 Allograft rejection 💬
1件: TNFRSF5 💬 Ravagalimab 💬 Ravagalimab 3件: 46, 53, 97 💬
4 Asthma 💬
1件: TNFRSF5 💬 Bleselumab 💬 Bleselumab 1件: 222 💬
5 Asthma 💬
1件: TNFRSF5 💬 Iscalimab 💬 Iscalimab 2件: 49, 53 💬
6 Asthma 💬
1件: TNFRSF5 💬 Ravagalimab 💬 Ravagalimab 3件: 46, 53, 97 💬
7 Autoimmune thyroid disease 💬
1件: TNFRSF5 💬 Bleselumab 💬 Bleselumab 1件: 222 💬
8 Autoimmune thyroid disease 💬
1件: TNFRSF5 💬 Iscalimab 💬 Iscalimab 2件: 49, 53 💬
9 Autoimmune thyroid disease 💬
1件: TNFRSF5 💬 Ravagalimab 💬 Ravagalimab 3件: 46, 53, 97 💬
10 Cell adhesion molecules 💬
1件: TNFRSF5 💬 Bleselumab 💬 Bleselumab 1件: 222 💬
11 Cell adhesion molecules 💬
1件: TNFRSF5 💬 Iscalimab 💬 Iscalimab 2件: 49, 53 💬
12 Cell adhesion molecules 💬
1件: TNFRSF5 💬 Ravagalimab 💬 Ravagalimab 3件: 46, 53, 97 💬
13 Cytokine-cytokine receptor interaction 💬
1件: TNFRSF5 💬 Bleselumab 💬 Bleselumab 1件: 222 💬
14 Cytokine-cytokine receptor interaction 💬
1件: TNFRSF5 💬 Iscalimab 💬 Iscalimab 2件: 49, 53 💬
15 Cytokine-cytokine receptor interaction 💬
1件: TNFRSF5 💬 Ravagalimab 💬 Ravagalimab 3件: 46, 53, 97 💬
16 Epstein-Barr virus infection 💬
1件: TNFRSF5 💬 Bleselumab 💬 Bleselumab 1件: 222 💬
17 Epstein-Barr virus infection 💬
1件: TNFRSF5 💬 Iscalimab 💬 Iscalimab 2件: 49, 53 💬
18 Epstein-Barr virus infection 💬
1件: TNFRSF5 💬 Ravagalimab 💬 Ravagalimab 3件: 46, 53, 97 💬
19 Human T-cell leukemia virus 1 infection 💬
1件: TNFRSF5 💬 Bleselumab 💬 Bleselumab 1件: 222 💬
20 Human T-cell leukemia virus 1 infection 💬
1件: TNFRSF5 💬 Iscalimab 💬 Iscalimab 2件: 49, 53 💬
21 Human T-cell leukemia virus 1 infection 💬
1件: TNFRSF5 💬 Ravagalimab 💬 Ravagalimab 3件: 46, 53, 97 💬
22 Intestinal immune network for IgA production 💬
1件: TNFRSF5 💬 Bleselumab 💬 Bleselumab 1件: 222 💬
23 Intestinal immune network for IgA production 💬
1件: TNFRSF5 💬 Iscalimab 💬 Iscalimab 2件: 49, 53 💬
24 Intestinal immune network for IgA production 💬
1件: TNFRSF5 💬 Ravagalimab 💬 Ravagalimab 3件: 46, 53, 97 💬
25 Lipid and atherosclerosis 💬
1件: TNFRSF5 💬 Bleselumab 💬 Bleselumab 1件: 222 💬
26 Lipid and atherosclerosis 💬
1件: TNFRSF5 💬 Iscalimab 💬 Iscalimab 2件: 49, 53 💬
27 Lipid and atherosclerosis 💬
1件: TNFRSF5 💬 Ravagalimab 💬 Ravagalimab 3件: 46, 53, 97 💬
28 Malaria 💬
1件: TNFRSF5 💬 Bleselumab 💬 Bleselumab 1件: 222 💬
29 Malaria 💬
1件: TNFRSF5 💬 Iscalimab 💬 Iscalimab 2件: 49, 53 💬
30 Malaria 💬
1件: TNFRSF5 💬 Ravagalimab 💬 Ravagalimab 3件: 46, 53, 97 💬
31 NF-kappa B signaling pathway 💬
1件: TNFRSF5 💬 Bleselumab 💬 Bleselumab 1件: 222 💬
32 NF-kappa B signaling pathway 💬
1件: TNFRSF5 💬 Iscalimab 💬 Iscalimab 2件: 49, 53 💬
33 NF-kappa B signaling pathway 💬
1件: TNFRSF5 💬 Ravagalimab 💬 Ravagalimab 3件: 46, 53, 97 💬
34 Primary immunodeficiency 💬
1件: TNFRSF5 💬 Bleselumab 💬 Bleselumab 1件: 222 💬
35 Primary immunodeficiency 💬
1件: TNFRSF5 💬 Iscalimab 💬 Iscalimab 2件: 49, 53 💬
36 Primary immunodeficiency 💬
1件: TNFRSF5 💬 Ravagalimab 💬 Ravagalimab 3件: 46, 53, 97 💬
37 Systemic lupus erythematosus 💬
1件: TNFRSF5 💬 Bleselumab 💬 Bleselumab 1件: 222 💬
38 Systemic lupus erythematosus 💬
1件: TNFRSF5 💬 Iscalimab 💬 Iscalimab 2件: 49, 53 💬
39 Systemic lupus erythematosus 💬
1件: TNFRSF5 💬 Ravagalimab 💬 Ravagalimab 3件: 46, 53, 97 💬
40 Toll-like receptor signaling pathway 💬
1件: TNFRSF5 💬 Bleselumab 💬 Bleselumab 1件: 222 💬
41 Toll-like receptor signaling pathway 💬
1件: TNFRSF5 💬 Iscalimab 💬 Iscalimab 2件: 49, 53 💬
42 Toll-like receptor signaling pathway 💬
1件: TNFRSF5 💬 Ravagalimab 💬 Ravagalimab 3件: 46, 53, 97 💬
43 Toxoplasmosis 💬
1件: TNFRSF5 💬 Bleselumab 💬 Bleselumab 1件: 222 💬
44 Toxoplasmosis 💬
1件: TNFRSF5 💬 Iscalimab 💬 Iscalimab 2件: 49, 53 💬
45 Toxoplasmosis 💬
1件: TNFRSF5 💬 Ravagalimab 💬 Ravagalimab 3件: 46, 53, 97 💬
46 Transcriptional misregulation in cancer 💬
1件: TNFRSF5 💬 Bleselumab 💬 Bleselumab 1件: 222 💬
47 Transcriptional misregulation in cancer 💬
1件: TNFRSF5 💬 Iscalimab 💬 Iscalimab 2件: 49, 53 💬
48 Transcriptional misregulation in cancer 💬
1件: TNFRSF5 💬 Ravagalimab 💬 Ravagalimab 3件: 46, 53, 97 💬
49 Viral myocarditis 💬
1件: TNFRSF5 💬 Bleselumab 💬 Bleselumab 1件: 222 💬
50 Viral myocarditis 💬
1件: TNFRSF5 💬 Iscalimab 💬 Iscalimab 2件: 49, 53 💬
51 Viral myocarditis 💬
1件: TNFRSF5 💬 Ravagalimab 💬 Ravagalimab 3件: 46, 53, 97 💬